CATALAYER NEWS

Amarin’s icosapent ethyl shows survival benefit in cancer trial

Source: Investing.com · 2026-10-25

Full article text is available in the Catalayer news terminal.

MORE FROM INVESTING.COM
Medpace CEO August Troendle sells $1.59 million in stock
2026-10-25
ArriVent reports phase 1 data for cancer drug ARR-217
2026-10-25
Earnings flood, Fed meeting will test rickety AI market rally
2026-10-25
Earnings flood, Fed meeting will test rickety AI market rally By Reuters - Investing.com
2026-10-25
UK’s Rayner says no Brexit reopening as Burnham floats EU free movement
2026-10-25
RELATED ON CATALAYER
Related Topics
Crypto & Digital Asset News
RELATED MARKETS
Prediction Markets
Xi Jinping out before 2027?4%Will Gavin Newsom win the 2028 Democratic presidential nomination?17%Will Alexandria Ocasio-Cortez win the 2028 Democratic presidential nomination?17%
Open Catalayer terminal for live tracking →